Women in BIO Luncheon

Please join Women In Bio and your industry colleagues for a luncheon featuring Dr. Janet Woodcock.

Dr. Woodcock, with over 20 years in senior leadership roles at FDA, is at the center of every major issue relating to the regulation of biopharmaceutical products.  She will address some of the critical issues and initiatives at CDER impacting the  development and approval of therapeutic drug and biologic products, including oversight of clinical research, efforts to speed the drug development and approval process, drug and diagnostic co-development, the new biosimilars framework, and post-market drug safety.